Perioperative Blood Management Strategies for Patients Undergoing Total Hip Arthroplasty: Where Do We Currently Stand on This Matter?



1 Bank of Cyprus Oncology Center, Acropoleos Ave 32, Strovolos, Nicosia, Cyprus

2 George Eliot Hospital NHS Trust, Nuneaton, Warwickshire

3 Democritus University of Thrace, University General Hospital of Alexandroupolis, Alexandroupolis, Dragana, Greece

4 Whitechapel Rd, Whitechapel, London, UK


Total hip replacement (THR) has proved to be a reliable treatment for the end stage of hip osteoarthritis. It is a
common orthopaedic procedure with excellent results, but is associated with significant blood loss and high rates
of allogeneic blood transfusion (ABT). The potential complications and adverse events after ABT, combined with the
ongoing research, have resulted in multimodel, multidisciplinary blood management strategies adoption, aiming to
reduce the blood loss and transfusion rates. Many reviews and meta-analyses have tried to demonstrate the best
blood management strategies. The purpose of this study is to review any evidence-based blood conserving technique,
dividing them in three stages: preoperative, intraoperative and postoperative.
Level of evidence: III


1. Liu XW, Zi Y, Xiang LB, Wang Y. Total hip arthroplasty:
areview of advances, advantages and limitations. Int
J Clin Exp Med. 2015 ;8(1):27–36.
2. Sehat KR, Evans RL, Newman JH. Hidden blood
loss following hip and knee arthroplasty. Correct
management of blood loss should take hidden loss
into account. J Bone Joint Surg Br. 2004 ;86(4):561–5.
3. Kamath AF, Pagnano MW. Blood Management for
Patients Undergoing Total Joint Arthroplasty: JBJS
Rev. 2013 ;1(2).
4. Saleh A, Small T, Chandran Pillai ALP, Schiltz NK,
Klika AK, Barsoum WK. Allogenic blood transfusion
following total hip arthroplasty: results from the
nationwide inpatient sample, 2000 to 2009. J Bone
Joint Surg Am. 2014 ;96(18):e155 (1-10).
5. Yoshihara H, Yoneoka D. National trends in the
utilization of blood transfusions in total hip and knee
arthroplasty. J Arthroplasty. 2014 ;29(10):1932–7.
6. Delaney M, Wendel S, Bercovitz RS, Cid J, Cohn C,
Dunbar NM et al, Biomedical Excellence for Safer
Transfusion (BEST) Collaborative. Transfusion
reactions: prevention, diagnosis, and treatment.
Lancet Lond Engl. 2016 ;388(10061):2825–36.
7. Frazier SK, Higgins J, Bugajski A, Jones AR, Brown
MR. Adverse Reactions to Transfusion of Blood
Products and Best Practices for Prevention. Crit Care
Nurs Clin North Am. 2017 ;29(3):271–90.
8. Bong MR, Patel V, Chang E, Issack PS, Hebert R, Di
Cesare PE. Risks associated with blood transfusion
after total knee arthroplasty. J Arthroplasty. 2004;
9. Spahn DR. Anemia and patient blood management
in hip and knee surgery: a systematic review of the
literature. Anesthesiology. 2010 ;113(2):482–95.
10. Park JH, Rasouli MR, Mortazavi SMJ, Tokarski AT,
Maltenfort MG, Parvizi J. Predictors of perioperative
blood loss in total joint arthroplasty. J Bone Joint
Surg Am. 2013 ;95 (19):1777–83.
11. Marson BA, Shah J, Deglurkar M. Blood transfusion
in hip and knee arthroplasties: the end of the
pre-operative group and save? Eur J Orthop Surg
Traumatol Orthop Traumatol. 2015 ;25(5):871–5.
12. Loftus TJ, Spratling L, Stone BA, Xiao L, Jacofsky DJ.
A Patient Blood Management Program in Prosthetic
Joint Arthroplasty Decreases Blood Use and Improves
Outcomes. J Arthroplasty. 2016 ;31(1):11–4.
13. Bedard NA, Pugely AJ, Lux NR, Liu SS, Gao Y, Callaghan
JJ. Recent Trends in Blood Utilization After Primary
Hip and Knee Arthroplasty. J Arthroplasty. 2017;
14. McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist
B. Worldwide prevalence of anaemia, WHO Vitamin
and Mineral Nutrition Information System, 1993-
2005. Public Health Nutr. 2009 ;12(4):444–54.
15. Muñoz M, Gómez-Ramí􀆴rez S, Kozek-Langeneker
S, Shander A, Richards T, Paví􀆴a J et al. ‘Fit to fly’:
overcoming barriers to preoperative haemoglobin
optimization in surgical patients. Br J Anaesth. 2015;
16. Lasocki S, Krauspe R, von Heymann C, Mezzacasa A,
Chainey S, Spahn DR. PREPARE: the prevalence of
perioperative anaemia and need for patient blood
management in elective orthopaedic surgery: a
multicentre, observational study. Eur J Anaesthesiol.
2015 ;32(3):160–7.
17. Kearney B, To J, Southam K, Howie D, To B. Anaemia
in elective orthopaedic surgery - Royal Adelaide
Hospital, Australia. Intern Med J. 2016;46(1):96–101.
18. Jans Ø, Nielsen CS, Khan N, Gromov K, Troelsen A,
Husted H. Iron deficiency and preoperative anaemia
in patients scheduled for elective hip- and knee
arthroplasty - an observational study. Vox Sang.
2018 ;113(3):260–7.
19. Goodnough LT, Maniatis A, Earnshaw P, Benoni
G, Beris P, Bisbe E et al. Detection, evaluation, and
management of preoperative anaemia in the elective
orthopaedic surgical patient: NATA guidelines. Br J
Anaesth. 2011 ;106(1):13–22.
20. Kristensen SD, Knuuti J, Saraste A, Anker S, Bøtker
HE, Hert SD et al. 2014 ESC/ESA Guidelines on
non-cardiac surgery: cardiovascular assessment
and management The Joint Task Force on noncardiac
surgery: cardiovascular assessment and
management of the European Society of Cardiology
(ESC) and the European Society of Anaesthesiology
(ESA). Eur Heart J. 2014 ;35(35):2383–431.
21. Di Minno MND, Prisco D, Ruocco AL, Mastronardi
P, Massa S, Di Minno G. Perioperative handling
of patients on antiplatelet therapy with need for
surgery. Intern Emerg Med. 2009 ;4(4):279–88.
22. Biondi-Zoccai GGL, Lotrionte M, Agostoni P, Abbate
A, Fusaro M, Burzotta F et al. A systematic review
and meta-analysis on the hazards of discontinuing
or not adhering to aspirin among 50,279 patients
at risk for coronary artery disease. Eur Heart J.
23. Oscarsson A, Gupta A, Fredrikson M, Järhult J,
Nyström M, Pettersson E et al. To continue or
discontinue aspirin in the perioperative period: a
randomized, controlled clinical trial. Br J Anaesth.
2010 ;104(3):305–12.
24. Sundström J, Hedberg J, Thuresson M, Aarskog
P, Johannesen KM, Oldgren J. Low-Dose Aspirin
Discontinuation and Risk of Cardiovascular Events:
A Swedish Nationwide, Population-Based Cohort
Study. Circulation. 2017 ;136(13):1183–92.
25. Horlocker TT, Wedel DJ, Rowlingson JC, Enneking
FK, Kopp SL, Benzon HT et al. Regional anesthesia in
the patient receiving antithrombotic or thrombolytic
therapy: American Society of Regional Anesthesia
and Pain Medicine Evidence-Based Guidelines (Third
Edition). Reg Anesth Pain Med. 2010 ;35(1):64–101.
26. Burger W, Chemnitius J-M, Kneissl GD, Rücker G.
Low-dose aspirin for secondary cardiovascular
prevention - cardiovascular risks after its
perioperative withdrawal versus bleeding risks with
its continuation - review and meta-analysis. J Intern
Med. 2005 ;257(5):399–414.
27. Rossini R, Musumeci G, Visconti LO, Bramucci
E, Castiglioni B, De Servi S et al. Perioperative
management of antiplatelet therapy in patients 
with coronary stents undergoing cardiac and noncardiac
surgery: a consensus document from Italian
cardiological, surgical and anaesthesiological
societies. EuroIntervention J Eur Collab Work Group
Interv Cardiol Eur Soc Cardiol. 2014; 10(1):38–46.
28. Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD,
Fleisher LA et al. 2016 ACC/AHA Guideline Focused
Update on Duration of Dual Antiplatelet Therapy in
Patients With Coronary Artery Disease. J Am Coll
Cardiol. 2016 ;68(10):1082–115.
29. Authors/Task Force members, Windecker S,
Kolh P, Alfonso F, Collet JP et al. 2014 ESC/EACTS
Guidelines on myocardial revascularization: The
Task Force on Myocardial Revascularization of
the European Society of Cardiology (ESC) and the
European Association for Cardio-Thoracic Surgery
(EACTS)Developed with the special contribution
of the European Association of Percutaneous
Cardiovascular Interventions (EAPCI). Eur Heart J.
2014 ;35(37):2541–619.
30. Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F,
Jeppsson A et al. 2017 ESC focused update on dual
antiplatelet therapy in coronary artery disease
developed in collaboration with EACTS: The Task
Force for dual antiplatelet therapy in coronary artery
disease of the European Society of Cardiology (ESC)
and of the European Association for Cardio-Thoracic
Surgery (EACTS). Eur Heart J. 2018 ;39(3):213–60.
31. Merritt JC, Bhatt DL. The efficacy and safety of
perioperative antiplatelet therapy. J Thromb
Thrombolysis. 2004 ;17(1):21–7.
32. Abualsaud AO, Eisenberg MJ. Perioperative
Management of Patients With Drug-Eluting Stents.
JACC Cardiovasc Interv. 2010 ;3(2):131–42.
33. Dimitrova G, Tulman DB, Bergese SD. Perioperative
management of antiplatelet therapy in patients
with drug-eluting stents. HSR Proc Intensive Care
Cardiovasc Anesth. 2012 ;4(3):153–67.
34. Kasparek MF, Faschingbauer M, Waldstein W,
Boettner CS, Boettner F. Topical Tranexamic Acid
is Equivalent to Targeted Preoperative Autologous
Blood Donation in Total Hip Arthroplasty. J
Arthroplasty. 2017; 32(4):1176–9.
35. Kim JL, Park JH, Han SB, Cho IY, Jang KM. Allogeneic
Blood Transfusion Is a Significant Risk Factor for
Surgical-Site Infection Following Total Hip and Knee
Arthroplasty: A Meta-Analysis. J Arthroplasty. 2017;
36. Everhart JS, Sojka JH, Mayerson JL, Glassman AH,
Scharschmidt TJ. Perioperative Allogeneic Red
Blood-Cell Transfusion Associated with Surgical Site
Infection After Total Hip and Knee Arthroplasty. J
Bone Joint Surg Am. 2018 ;100(4):288–94.
37. Salpeter SR, Buckley JS, Chatterjee S. Impact of more
restrictive blood transfusion strategies on clinical
outcomes: a meta-analysis and systematic review.
Am J Med. 2014 ;127(2):124-131.
38. Holst LB, Petersen MW, Haase N, Perner A, Wetterslev
J. Restrictive versus liberal transfusion strategy
for red blood cell transfusion: systematic review
of randomised trials with meta-analysis and trial 
sequential analysis. BMJ. 2015 ;350:h1354.
39. Carson JL, Guyatt G, Heddle NM, Grossman BJ, Cohn
CS, Fung MK, et al. Clinical Practice Guidelines From
the AABB: Red Blood Cell Transfusion Thresholds
and Storage. JAMA. 2016 ;316(19):2025–35.
40. Klein AA, Arnold P, Bingham RM, Brohi K, Clark
R, Collis R et al. AAGBI guidelines: the use of
blood components and their alternatives 2016.
Anaesthesia. 2016 ;71(7):829–42.
41. Memtsoudis SG, Sun X, Chiu YL, Stundner O, Liu
SS, Banerjee S et al. Perioperative comparative
effectiveness of anesthetic technique in orthopedic
patients. Anesthesiology. 2013 ;118(5):1046–58.
42. Johnson RL, Kopp SL, Burkle CM, Duncan CM, Jacob
AK, Erwin PJ et al. Neuraxial vs general anaesthesia
for total hip and total knee arthroplasty: a systematic
review of comparative-effectiveness research. Br J
Anaesth. 2016 ;116(2):163–76.
43. Basques BA, Toy JO, Bohl DD, Golinvaux NS, Grauer
JN. General compared with spinal anesthesia
for total hip arthroplasty. J Bone Joint Surg Am.
44. Helwani MA, Avidan MS, Ben Abdallah A, Kaiser DJ,
Clohisy JC, Hall BL et al. Effects of regional versus
general anesthesia on outcomes after total hip
arthroplasty: a retrospective propensity-matched
cohort study. J Bone Joint Surg Am. 2015;97(3):
45. Sharrock NE, Salvati EA. Hypotensive epidural
anesthesia for total hip arthroplasty: a review. Acta
Orthop Scand. 1996 ;67(1):91–107.
46. Eroglu A, Uzunlar H, Erciyes N. Comparison of
hypotensive epidural anesthesia and hypotensive
total intravenous anesthesia on intraoperative blood
loss during total hip replacement. J Clin Anesth.
2005 ;17(6):420–5.
47. Niemi TT, Pitkänen M, Syrjälä M, Rosenberg PH.
Comparison of hypotensive epidural anaesthesia
and spinal anaesthesia on blood loss and coagulation
during and after total hip arthroplasty. Acta
Anaesthesiol Scand. 2000 ;44(4):457–64.
48. Lee YC, Park SJ, Kim JS, Cho CH. Effect of tranexamic
acid on reducing postoperative blood loss in
combined hypotensive epidural anesthesia and
general anesthesia for total hip replacement. J Clin
Anesth. 2013 ;25(5):393–8.
49. Moonen AFCM, Neal TD, Pilot P. Peri-operative
blood management in elective orthopaedic surgery.
A critical review of the literature. Injury. 2006 ;37
Suppl 5:S11-16.
50. Olsfanger D, Jedeikin R, Metser U, Nusbacher J,
Gepstein R. Acute normovolaemic haemodilution and
idiopathic scoliosis surgery: effects on homologous
blood requirements. Anaesth Intensive Care. 1993;
51. Oishi CS, D’Lima DD, Morris BA, Hardwick ME,
Berkowitz SD, Colwell CW. Hemodilution with other
blood reinfusion techniques in total hip arthroplasty.
Clin Orthop. 1997 ;(339)132–9.
52. Karakaya D, Ustün E, Tür A, Bariş S, Sarihasan B,
Sahinoğlu H et al. Acute normovolemic hemodilution 
and nitroglycerin-induced hypotension: comparative
effects on tissue oxygenation and allogeneic blood
transfusion requirement in total hip arthroplasty. J
Clin Anesth. 1999; 11(5):368–74.
53. Zhou X, Zhang C, Wang Y, Yu L, Yan M. Preoperative
Acute Normovolemic Hemodilution for Minimizing
Allogeneic Blood Transfusion: A Meta-Analysis.
Anesth Analg. 2015 ;121(6):1443–55.
54. Li J, Zhang Z, Chen J. Comparison of efficacy and
safety of topical versus intravenous tranexamic acid
in total hip arthroplasty: A meta-analysis. Medicine
(Baltimore). 2016 ;95(36):e4689.
55. Zhang P, Liang Y, Chen P, Fang Y, He J, Wang
J. Combined application versus topical and
intravenous application of tranexamic acid following
primary total hip arthroplasty: a meta-analysis. BMC
Musculoskelet Disord. 2017 ;18(1):90.
56. Zhang LK, Ma JX, Kuang MJ, Zhao J, Wang Y, Lu B et al.
Comparison of oral versus intravenous application of
tranexamic acid in total knee and hip arthroplasty: A
systematic review and meta-analysis. Int J Surg Lond
Engl. 2017 ;45:77–84.
57. Luo ZY, Wang D, Meng WK, Wang HY, Pan H, Pei FX
et al. Oral tranexamic acid is equivalent to topical
tranexamic acid without drainage in primary total
hip arthroplasty: A double-blind randomized clinical
trial. Thromb Res. 2018 ;167:1–5.
58. Fillingham YA, Ramkumar DB, Jevsevar DS, Yates AJ,
Shores P, Mullen K et al. The Efficacy of Tranexamic
Acid in Total Knee Arthroplasty: A Network Meta-
Analysis. J Arthroplasty. 2018 ;33(10):3090-3098.
59. Churchill JL, Puca KE, Meyer ES, Carleton MC, Truchan
SL, Anderson MJ. Comparison of ε-Aminocaproic
Acid and Tranexamic Acid in Reducing Postoperative
Transfusions in Total Hip Arthroplasty. J Arthroplasty.
2016 ;31(12):2795-2799.
60. Dong Q, Zhang Y, Sun X, Hu F. The effectiveness and
safety of aminocaproic acid for reducing blood loss
in total knee and hip arthroplasty: A meta-analysis.
Int J Surg Lond Engl. 2018 ;52:156–63.
61. Colwell CW, Chelly JE, Murkin JM, Stevens D, O’Keefe
TJ, Hall R et al. Randomized study of aprotinin effect
on transfusions and blood loss in primary THA. Clin
Orthop. 2007 ;465:189–95.
62. Duramaz A, Bilgili MG, Bayram B, Ziroğlu N, Edipoğlu
E, Ö􀇆 neş HN et al. The role of intraoperative cell
salvage system on blood management in major
orthopedic surgeries: a cost–benefit analysis. Eur J
Orthop Surg Traumatol. 2018 ;28(5):991–7.
63. Buget MI, Dikici F, Edipoğlu İ􀇚S, Yıldız E, Valiyev N,
Kucukay S. Two-year experience with cell salvage
in total hip arthroplasty. Braz J Anesthesiol Elsevier.
2016 ;66(3):276–82.
64. Mason L, Fitzgerald C, Powell-Tuck J, Rice R.
Intraoperative cell salvage versus postoperative
autologous blood transfusion in hip arthroplasty:
a retrospective service evaluation. Ann R Coll Surg
Engl. 2011 ;93(5):398–400.
65. Sikorski RA, Rizkalla NA, Yang WW, Frank SM.
Autologous blood salvage in the era of patient blood
management. Vox Sang. 2017 ;112(6):499–510.
66. Meermans G, Konan S, Das R, Volpin A, Haddad
FS. The direct anterior approach in total hip
arthroplasty: a systematic review of the literature.
Bone Jt J. 2017;99-B(6):732–40.
67. Xu CP, Li X, Song JQ, Cui Z, Yu B. Mini-Incision versus
Standard Incision Total Hip Arthroplasty Regarding
Surgical Outcomes: A Systematic Review and Meta-
Analysis of Randomized Controlled Trials. PLOS
ONE. 2013 ;8(11):e80021
68. Parvizi J, Restrepo C, Maltenfort MG. Total hip
arthroplasty performed through direct anterior
approach provides superior early outcome: results
of a randomized, prospective study. Orthop Clin
North Am. 2016;47(3):497 –504
69. Mjaaland KE, Kivle K, Svenningsen S, Pripp AH,
Nordsletten L. Comparison of markers for muscle
damage, inflammation, and pain using minimally
invasive direct anterior versus direct lateral
approach in total hip arthroplasty: a prospective,
randomized, controlled trial. J Orthop Res : official
publication of the Orthopaedic Research Society.
2015;33(9):1305 –10
70. Mjaaland KE, Kivle K, Svenningsen S, Pripp AH,
Nordsletten L. Comparison of markers for muscle
damage, inflammation, and pain using minimally
invasive direct anterior versus direct lateral
approach in total hip arthroplasty: a prospective,
randomized, controlled trial. J Orthop Res : official
publication of the Orthopaedic Research Society.
2015;33(9):1305 –10.
71. Mayr E, Nogler M, Benedetti MG, Kessler O, Reinthaler
A, Krismer M, Leardini A. A prospective randomized
assessment of earlier functional recovery in THA
patients treated by minimally invasive direct anterior
approach: a gait analysis study. Clin Biomech (Bristol,
Avon). 2009;24(10):812 –8.
72. Maltenfort M. CORR InsightsTM: Is Limited Incision
Better Than Standard Total Hip Arthroplasty? A
Meta-Analysis. Clin Orthop. 2013 ;471(4):1297–8.
73. Jackson MR. Fibrin sealants in surgical practice: An
overview. Am J Surg. 2001 ;182(2 Suppl):1S-7S.
74. Li J, Li HB, Zhai XC, Qin-Lei, Jiang XQ, Zhang ZH.
Topical use of topical fibrin sealant can reduce the
need for transfusion, total blood loss and the volume
of drainage in total knee and hip arthroplasty: A
systematic review and meta-analysis of 1489 patients.
Int J Surg Lond Engl. 2016 ;36(Pt A):127–37.
75. Zhao Z, Ma X, Ma J, Sun X, Li F, Lv J. A Systematic Review
and Meta-analysis of the Topical Administration of
Fibrin Sealant in Total Hip Arthroplasty. Sci Rep.
2018 ;8(1):78.
76. Huang Z, Ma J, Shen B, Yang J, Zhou Z, Kang P et al. Use
of a Bipolar Blood-Sealing System During Total Joint
Arthroplasty. Orthopedics. 2015 ;38(12):757–63.
77. Yang Y, Zhang LC, Xu F, Li J, Lv YM. Bipolar sealer not
superior to standard electrocautery in primary total
hip arthroplasty: a meta-analysis. J Orthop Surg.
2014 ;9:92.
78. Min JK, Zhang QH, Li HD, Li H, Guo P. The Efficacy
of Bipolar Sealer on Blood Loss in Primary Total Hip
Arthroplasty: A Meta-Analysis. Medicine (Baltimore).
79. Sampson S, Gerhardt M, Mandelbaum B. Platelet rich
plasma injection grafts for musculoskeletal injuries:
a review. Curr Rev Musculoskelet Med. 2008; 1(3-
80. Hussain N, Johal H, Bhandari M. An evidence-based
evaluation on the use of platelet rich plasma in
orthopedics - a review of the literature. SICOT-J.
81. Ma J, Sun J, Guo W, Li Z, Wang B, Wang W. The effect
of platelet-rich plasma on reducing blood loss
after total knee arthroplasty: A systematic review
and meta-analysis. Medicine (Baltimore). 2017;
82. Brossi PM, Moreira JJ, Machado TS, Baccarin
RY. Platelet-rich plasma in orthopedic therapy:
a comparative systematic review of clinical
and experimental data in equine and human
musculoskeletal lesions. BMC Vet Res. 2015 ;11:98.
83. Waugh TR, Stinchfield FE. Suction drainage of
orthopaedic wounds. J Bone Joint Surg Am. 1961;
84. Zhou X, Li J, Xiong Y, Jiang L, Li W, Wu L. Do we
really need closed-suction drainage in total
hip arthroplasty? A meta-analysis. Int Orthop.
85. Chen ZY, Gao Y, Chen W, Li X, Zhang YZ. Is wound
drainage necessary in hip arthroplasty? A metaanalysis
of randomized controlled trials. Eur J
Orthop Surg Traumatol Orthop Traumatol. 2014
86. Kelly EG, Cashman JP, Imran FH, Conroy R, O’Byrne
J. Systematic review and meta-analysis of closed
suction drainage versus non-drainage in primary hip
arthroplasty. Surg Technol Int. 2014 ;24:295–301.
87. Abramson DI, Chu LS, Tuck S, Lee SW, Richardson
G, Levin M. Effect of tissue temperatures and blood
flow on motor nerve conduction velocity. JAMA.
1966; 198(10):1082–8.
88. Algafly AA, George KP. The effect of cryotherapy on
nerve conduction velocity, pain threshold and pain
tolerance. Br J Sports Med. 2007 ;41(6):365–9.
89. Curl WW, Smith BP, Marr A, Rosencrance E, Holden
M, Smith TL. The effect of contusion and cryotherapy
on skeletal muscle microcirculation. J Sports Med
Phys Fitness. 1997 ;37(4):279–86.
90. Ni SH, Jiang WT, Guo L, Jin YH, Jiang TL, Zhao Y et al.
Cryotherapy on postoperative rehabilitation of joint
arthroplasty. Knee Surg Sports Traumatol Arthrosc
Off J ESSKA. 2015 ;23(11):3354–61.
91. Dusik CJ, Hutchison C, Langelier D. The merits of cell
salvage in arthroplasty surgery: an overview. Can J
Surg J Can Chir. 2014 ;57(1):61–6.
92. Xie J, Feng X, Ma J, Kang P, Shen B, Yang J et al. Is
postoperative cell salvage necessary in total hip or
knee replacement? A meta-analysis of randomized
controlled trials. Int J Surg Lond Engl. 2015 ;21:
93. Leigheb M, Pogliacomi F, Bosetti M, Boccafoschi F,
Sabbatini M, Cannas M et al. Postoperative blood
salvage versus allogeneic blood transfusion in total 
knee and hip arthroplasty: a literature review. Acta
Bio-Medica Atenei Parm. 2016 ;87 Suppl 1:6–14.
94. Oremus K, Sostaric S, Trkulja V, Haspl M. Influence
of tranexamic acid on postoperative autologous
blood retransfusion in primary total hip and
knee arthroplasty: a randomized controlled trial.
Transfusion (Paris). 2014 ;54(1):31–41.
95. Springer BD, Odum SM, Fehring TK. What Is the
Benefit of Tranexamic Acid vs Reinfusion Drains
in Total Joint Arthroplasty? J Arthroplasty. 2016;
96. Ramkumar DB, Ramkumar N, Tapp SJ, Moschetti
WE. Pharmacologic Hemostatic Agents in Total
Joint Arthroplasty-A Cost-Effectiveness Analysis. J
Arthroplasty. 2018 ;33(7):2092-2099.
97. Whitaker B, Hinkins S. 2011 National Blood
Collection and Utilization Survey Report. In: 1.
Executive Summary. p.3
Volume 8, Issue 6
November and December 2020
Pages 646-655
  • Receive Date: 12 January 2020
  • Revise Date: 22 February 2020
  • Accept Date: 08 April 2020
  • First Publish Date: 01 November 2020